Company attributes
Location
B2X
0
Founder
Pitchbook URL
Legal Name
Alpine Immune Sciences, Inc.
Number of Employees (Ranges)
51 – 200
Phone Number
+120678845450
Number of Employees
85
Full Address
188 E Blaine St, 200, Seattle, Washington 98102, US0
CIK Number
Place of Incorporation
Investors
DUNS Number
0797020940
IRS Number
208,969,4930
Founded Date
2015
Total Funding Amount (USD)
49,300,000
Latest Funding Round Date
June 13, 2016
Stock Symbol
ALPN0
Exchange
Board of Directors
CFO
Key People
Latest Funding Type
NAICS Code
325,4120
CAGE Code
7BAW80
Country
Other attributes
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
48,000,000
Previous Name
Nivalis Therapeutics, Inc.0
N30 Pharmaceuticals, Inc.0
Public/Private
Public
SIC Code
2,8340
Ticker Symbol
ALPN
Alpine Immune Sciences is a clinical-stage immunotherapy company developing treatments for cancer, autoimmune and inflammatory diseases. Immunotherapy candidates include ALPN-101 for Systemic Lupus Erythematosus, ALPN-202 for advanced malignancies and ALPN-303 for B cell-mediated inflammatory diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
